Biolase Inc
(BIOLQ)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,482 | -3,056 | -4,486 | -12,021 | -2,956 |
| Depreciation Amortization | 977 | 647 | 872 | 1,177 | 1,444 |
| Income taxes - deferred | -30 | 61 | 53 | 76 | 109 |
| Accounts receivable | 264 | -3,222 | -5,642 | 978 | -290 |
| Other Working Capital | -2,176 | -1,794 | -12,312 | 6,113 | -3,489 |
| Other Operating Activity | 3,151 | 5,700 | 8,195 | -135 | 2,611 |
| Operating Cash Flow | $-9,296 | $-1,664 | $-13,320 | $-3,812 | $-2,571 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -675 | -684 | -428 | -237 | -444 |
| Purchase Sale Intangibles | -10 | -14 | N/A | N/A | N/A |
| Other Investing Activity | -10 | -14 | 0 | 0 | 0 |
| Investing Cash Flow | $-685 | $-698 | $-428 | $-237 | $-444 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 35,100 | 16,600 | N/A | N/A | 4,293 |
| Debt Issued | N/A | N/A | N/A | 3,000 | 0 |
| Debt Repayment | 0 | N/A | -2,700 | -300 | 0 |
| Common Stock Issued | 5,908 | 461 | 18,485 | 199 | 173 |
| Common Stock Repurchased | N/A | -235 | -398 | N/A | 0 |
| Other Financing Activity | -32,161 | -15,267 | 0 | -85 | -9,697 |
| Financing Cash Flow | $8,847 | $1,559 | $15,387 | $2,814 | $-5,231 |
| Exchange Rate Effect | 31 | 39 | -26 | -46 | -14 |
| Beginning Cash Position | 2,543 | 3,307 | 1,694 | 2,975 | 11,235 |
| End Cash Position | 1,440 | 2,543 | 3,307 | 1,694 | 2,975 |
| Net Cash Flow | $-1,103 | $-764 | $1,613 | $-1,281 | $-8,260 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,296 | -1,664 | -13,320 | -3,812 | -2,571 |
| Capital Expenditure | -675 | -808 | -428 | -237 | -449 |
| Free Cash Flow | -9,971 | -2,472 | -13,748 | -4,049 | -3,020 |